Please assess the completion status of the following clinical trial:

Trial Title: A Prospective, Observational Study On The Effectiveness Of New Antiepileptic Drugs As First Bitherapy In The Daily Clinical Practice

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Aged 18 years or older.~* Diagnosis of focal epilepsy.~* Previous failure of one or more AEDs used in monotherapy.~* Background treatment with an antiepileptic drug.~* The investigator has considered that the patient must start treatment with some of the seven new AEDs in combination therapy: lamotrigine, levetiracetam, gabapentin, oxcarbazepine, pregabalin, tiagabine and/or topiramate.~* History of seizures in the patient in the past 3 months.~* The patient or legal guardian must be able to understand the characteristics of the study and fill in the seizure diaries.~* Written informed consent.~Exclusion Criteria:~* Inability to comply with the study requirements.~* Diagnosis of generalized epilepsy or inability to establish if focal or generalized.~* Presence of serious or uncontrolled systemic disease, serious psychiatric disease or progressive neurological disease.~* History of alcoholism, drug addiction, or abuse of medicines in the past two years.~* Psychogenic seizures in the two years prior to inclusion in the study.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1.0 (Type: OTHER): None

Based on this trial design, predict the completion outcome and termination type (if applicable).